The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis

Abstract Aims Optimal medical therapy after cardiac resynchronization therapy (CRT) implantation is important in heart failure (HF) with reduced ejection fraction (HFrEF) patients. Although sacubitril/valsartan (SV) is a mainstay in the treatment of HFrEF, its efficacy in the management of CRT non‐r...

全面介紹

書目詳細資料

Principais autores:	Kyeong‐Hyeon Chun, Jaewon Oh, Hee Tae Yu, Chan Joo Lee, Tae‐Hoon Kim, Jae Sun Uhm, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Seok‐Min Kang
格式:	Artigo
語言:	Inglês
出版:	Oxford University Press 2020-12-01
叢編:	ESC Heart Failure
主題:	Cardiac resynchronization therapy Heart failure with reduced ejection fraction Sacubitril/valsartan
在線閱讀:	https://doi.org/10.1002/ehf2.12988
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!